This experimental data is supported by human patient data showing that YAP or TAZ expression or nuclear localization is increased in metastatic tumors when compared to primary tumors in pancreatic cancer [87], breast cancer [86,139], and prostate cancer [140]. Here, YAP1 is linked to familial pancreatic carcinoma.